Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
N Engl J Med
.
2024 Jul 24.
doi: 10.1056/NEJMc2402088.
Online ahead of print.
Authors
Raphael J Landovitz
1
,
Sinead Delany-Moretlwe
2
,
Jessica M Fogel
3
,
Mark A Marzinke
3
,
Estelle Piwowar-Manning
3
,
Paul Richardson
3
,
Elias K Halvas
4
,
John W Mellors
4
,
Deborah Persaud
3
,
Ryan Kofron
5
,
Marybeth McCauley
6
,
Scott Rose
6
,
Alex R Rinehart
7
,
James F Rooney
8
,
Adeola Adeyeye
9
,
Myron S Cohen
10
,
Deborah Donnell
11
,
Mina C Hosseinipour
10
,
Beatriz Grinsztejn
12
,
Susan H Eshleman
3
;
HPTN 083 and 084 Study Teams
Affiliations
1
University of California, Los Angeles, Los Angeles, CA rlandovitz@mednet.ucla.edu.
2
University of the Witwatersrand, Johannesburg, South Africa.
3
Johns Hopkins University, Baltimore, MD.
4
University of Pittsburgh, Pittsburgh, PA.
5
University of California, Los Angeles, Los Angeles, CA.
6
FHI 360, Durham, NC.
7
ViiV Healthcare, Research Triangle Park, NC.
8
Gilead Sciences, Foster City, CA.
9
National Institutes of Health, Bethesda, MD.
10
University of North Carolina at Chapel Hill, Chapel Hill, NC.
11
Fred Hutchinson Cancer Center, Seattle, WA.
12
Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil.
PMID:
39046350
DOI:
10.1056/NEJMc2402088
No abstract available
Publication types
Letter
Grants and funding
U01 AI068619/AI/NIAID NIH HHS/United States
U01 AI069463/AI/NIAID NIH HHS/United States
UM1 AI068617/AI/NIAID NIH HHS/United States
UM1 AI069424/AI/NIAID NIH HHS/United States